Drug Development

Michelle Hoffman, editorial director of Pharmaceutical Technology.

Articles

The second annual Pharmaceutical Technology Bioprocessing Survey offers a snapshot of the industry following 2009's megamergers.

Trends in Bioprocessing

Merck To Eliminate 15,000 jobs; Tauzin Stepping Down At PhRMA; And More.

Week Of Feb. 22, 2010: Company And People Notes: Merck To Eliminate 15,000 Jobs; Tauzin Stepping Down At PhRMA; And More.

RUSNANO, a corporation established by the Russian government to foster the development of nanotechnology, launched a project last week to manufacture targeted-delivery nanodrugs to treat malignant neoplasms.

Russian Groups Agree to Produce Anticancer Nanodrugs

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

The Society for Chemical Manufacturers and Affiliates offered its support for a Senate proposal to extend to 2015 current chemical-security standards, the Chemical Facility Anti-Terrorism Standards, which are set to expire this year.

SOCMA Lends Support for Senate Chemical Security Bill

Abbott Completes Acquisition Of Solvay; Merck Names President of Consumer Healthcare; And More.

Week Of Feb. 15, 2010: Company And People Notes: Abbott Completes Acquisition Of Solvay; Merck Names President Of Consumer Healthcare; And More.

Personalized medicine is still a nascent area for pharmaceutical companies, but several large companies recently reported developments in this area.

Pfizer, Bayer, and BMS Advance Personalized-Medicine Products

GSK Chief Executive Andrew Witty outlined the company's strategic priorities for 2010, which include further diversification into emerging markets, consumer healthcare, and vaccines.

GSK Plans Further Restructuring in R&D

Margaret Hamburg, commissioner of the US Food and Drug Administration, unveiled a new program to improve the efficiency of import inspections.

FDA Unveils PREDICT System for Import Inspections

VaxGen Shareholders Reject OXiGENE Merger; Roche Creates Research Hub In Singapore; And More.

Week Of Feb. 8, 2010: Company And People Notes: VaxGen Shareholders Reject OXiGENE Merger; Roche Creates Research Hub In Singapore; And More.

Pfizer's first updated pipeline since its acquisition of Wyeth includes fewer projects than before and is targeted to specific diseases.

Ingredients